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I N T R O D U C T I O N
Transient receptor potential vanilloid (TRPV1) receptors have an indisputable role in the transduction and transmission of noxious stimuli and have been intensely studied since their cloning (Caterina et al. 1997 ). In the periphery, the TRPV1 receptor is viewed as a molecular integrator of chemical and physical noxious stimuli (Cortright and Szallasi 2004) . In contrast, the role of TRPV1 receptors in modulation of spinal cord synaptic transmission has not been entirely determined (Spicarova and Palecek 2008) . TRPV1 receptors are present in the mammalian spinal cord dorsal horn (DH), predominantly in laminae I and II, and the overwhelming majority of these receptors is expressed on central branches of small-and medium-sized dorsal root ganglion (DRG) neurons (Caterina et al. 1997; Guo et al. 1999) . Sporadic TRPV1 immunostaining has also been detected in superficial DH neurons and astrocytes (Doly et al. 2004a,b; Valtschanoff et al. 2001) .
Activation of TRPV1 receptors in the spinal cord is not fully understood, because no dramatic changes in temperature or pH that activate TRPV1 receptors in the periphery (Caterina et al. 1997 ) occur. A great effort has thus been used to detect endogenous agonists that could activate TRPV1 receptors in the CNS. Anandamide, a ligand of cannabinoid receptors, was one of the first substances suggested to act as an endogenous TRPV1 receptor ligand (Zygmunt et al. 1999) . Other substances include products of lipoxygenases (Hwang et al. 2000) , omega-3 polyunsaturated fatty acids , and N-arachidonoyldopamine (Huang et al. 2002) . N-oleoyldopamine (OLDA) induces calcium influx in TRPV1-transfected cells and thermal hyperalgesia after peripheral application in rats, whereas these effects were blocked by a TRPV1 antagonist (Chu et al. 2003; Szolcsanyi et al. 2004) .
The responses of TRPV1 receptors were shown to be modulated by a number of inflammatory substances, such as bradykinin (BK), histamine, nerve growth factor (NGF), prostaglandin E 2 , and serotonin, that lead to TRPV1 phosphorylation through protein kinase C (PKC) or protein kinase A (PKA) pathways (Cesare and McNaughton 1996; Lopshire and Nicol 1998; Shu and Mendell 2001; Vyklicky et al. 1998) . BK lowered the threshold for TRPV1 receptor heat activation to body temperature (Sugiura et al. 2002) , and PKC activation enhanced the responses evoked by the endogenous ligands (Premkumar and Ahern 2000) . In addition, TRPV1 receptor activation and responses to heat and agonist application are voltage dependent Voets et al. 2004) .
Behavioral studies showed a reduction in pain related behavior in neuropathic and inflammatory models after spinally acting TRPV1 antagonists (Cui et al. 2006; Kanai et al. 2005) and intrathecal injection of TRPV1 antisense oligonucleotides reduced mechanical neuropathic hypersensitivity (Christoph et al. 2007 ). An augmented role of spinal TRPV1 receptors under pathological conditions was also recently suggested (Lappin et al. 2006; Sikand and Premkumar 2007) .
In our experiments, the frequency of mEPSCs recorded from superficial DH neurons in acute spinal cord slices was used to investigate activation of TRPV1 receptors by the endogenous TRPV1 agonist, OLDA. The hypothesis was tested that a low concentration of OLDA that is ineffective under control conditions increases the mEPSC frequency after pretreatment with the PKC activator, phorbol 12-myristate 13-acetate (PMA), the inflammatory mediator bradykinin, or in slices from animals with induced peripheral inflammation.
M E T H O D S

Spinal cord slice preparation
Male Wistar rats postnatal days P19 -P23 were used. After anesthesia with pentobarbital sodium (90 mg/kg), the lumbar spinal cord was removed and immersed in oxygenated ice-cold dissection solution containing (in mM) 95 NaCl, 1.8 KCl, 7 MgSO 4 , 0.5 CaCl 2, 1.2 KH 2 PO 4 , 26 NaHCO 3 , 25 D-glucose, and 50 sucrose. The spinal cord was fixed to a vibratome stage using cyanoacrylate glue (VT 1000S; Leica) in a groove between two agar blocks. Acute transverse slices 300 -350 m thick were cut, incubated in the dissection solution for 30 min at 33°C, and stored in a recording solution at room temperature and allowed to recover for 1 h before the electrophysiological experiments. Recording solution contained (in mM) 127 NaCl, 1.8 KCl, 1.2 KH 2 PO 4 , 2.4 CaCl 2, 1.3 MgSO 4 , 26 NaHCO 3 , and 25 D-glucose. For the actual measurement, slices were transferred into a recording chamber that was perfused continuously with recording solution at a rate of ϳ2 ml/min. All extracellular solutions were saturated with carbogen (95% O 2 -5% CO 2 ) during the whole process.
Patch-clamp recording
Individual DH neurons were visualized using a differential interference contrast (DIC) microscope (DM LFSA; Leica) equipped with a 63 ϫ 0.90 water-immersion objective and an infrared-sensitive camera (IR camera, KP-200P; Hitachi) with a standard TV/video monitor (Hitachi VM-172). Patch pipettes were pulled from borosilicate glass tubing (Rückl Glass, Otvovice, Czech Republic). When filled with intracellular solution, they had resistances of 3.5-7.0 M⍀. The intracellular pipette solution contained (in mM) 125 gluconic acid lactone, 15 CsCl, 10 EGTA, 10 HEPES, 1 CaCl 2 , 2 Na 2 ATP, and 0.5 NaGTPand was adjusted to pH 7.2 with CsOH. Voltage-clamp recordings in the whole cell configuration were performed with an AxoPatch 1D amplifier (Molecular Devices) at room temperature (21-24°C) or at defined temperatures of 24 or 34°C. To record at the defined temperature, the extracellular solution was applied on the DH area of the spinal cord slice with a capillary of an application system. The precise temperature application system consisted of thin glass capillary equipped with temperature exchanger driven by a miniature Peltier device, insulated copper wire connected to a dc current source for resistive heating, and thermocouple for temperature measurement and microprocesor control (Dittel; Dittert et al. 2006) . Whole cell responses were low-pass filtered at 2 kHz and digitally sampled at 10 kHz. The series resistance of neurons was routinely compensated by 80% and was monitored during the whole experiment. AMPA receptor-mediated miniature excitatory postsynaptic currents (mEPSCs) were recorded from superficial DH neurons in laminae I and II and clamped at -70 mV in the presence of 10 M bicuculline, 5 M strychnine, and 0.5 M TTX. The software package pCLAMP version 9.0 (Axon Instruments, Foster City, CA) was used for data acquisition and subsequent off-line analysis. Cells with a series resistance Ͼ20 M⍀ were excluded from the analysis. Neurons with capsaicin sensitive primary afferent input were identified by the increase of mEPSC frequency (Ͼ20%) following capsaicin (0.1-0.2 M) administration at the end of the experimental protocol. It was difficult to keep the recording at 34°C for the whole duration of the experiment (ϳ30 min) when PMA application was tested. Therefore we switched between the two temperatures 24 and 34°C for data acquisition during the recording. The control values from cells recorded with this experimental protocol were also used as the control group for comparison with the group where peripheral inflammation was induced (Figs. 6 and 7). The change of mEPSC frequency induced by 5-min administration of PMA was measured at the end of 10-min washout after PMA application, before the second OLDA administration.
Peripheral inflammation
Peripheral inflammation was induced 24 h before the spinal cord slice preparation was made. Under ether anesthesia, both hindpaws were injected subcutaneously by a 3% mixture of kaolin and carrageenan in physiological saline solution. The animals were left to recover in their home cages.
Drug treatment
All drugs used in this study were of analytical grade and purchased from Sigma (St. Louis, MO), Tocris Cookson (Avonmouth, UK) or AnalaR (BDH Chemicals). Capsaicin, OLDA, SB366791, BCTC, and PMA were dissolved in dimethylsulfoxide (DMSO), which had a concentration Ͻ0.1% in the final solution. Drugs were applied in the recording solution.
Data analysis
Data segments of 2-min duration were analyzed for each drug. Only mEPSCs with amplitudes 5 pA or greater (which corresponded to at least twice the noise level) were included in the frequency analysis. In the case of amplitude analysis, the same criterion and data segments were used. Data are expressed as means Ϯ SE. Data were normalized as a percentage of the control values (100%). One-way ANOVA and one-way ANOVA repeated measures followed by a post hoc test (Student-Newman-Keuls, Bonferroni) were used for statistical comparisons, and P Ͻ 0.05 was considered statistically significant. A Kolmogorov-Smirnov test was used to evaluate statistical significance for cumulative data.
Behavioral experiments
Experiments were conducted in adult male Wistar rats (250 -300 g), kept in plastic cages with soft bedding with free access to food and water, maintained on a 12-h light, 12-h dark cycle. Paw withdrawal latency (PWL) to thermal stimulation was tested with radiant heat applied to the plantar surface of each hindpaw. Each paw was tested four times at each time interval, and mean values were calculated. The results from individual animals were averaged and tested for statistical significance with repeated-measures ANOVA and a post hoc Bonferroni test against control values before the drug administration. For intrathecal delivery of 20 l of vehicle (saline with 0.2% DMSO) or OLDA (100 and 500 M) followed by 40 l of saline intrathecally, lumbosacral catheters were implanted 1 wk before the experiment under ketamine (100 mg/kg, ip, Narkamon, Zentiva) and xylazine (10 mg/kg, im, Rometar, Zentiva) anesthesia. Catheters were constructed from polyethylene tubing (PE5), inserted intrathecally so the tip would reach the lumbar enlargement of the spinal cord, and were fixed with dental cement (Duracryl) to vertebral bones. The other end of each catheter was fixed to PE10 tubing and externalized on the back of the animal. Position of the catheters was verified by bolus injection of a dye at the end of each experiment.
All experiments were approved by the local Institutional Animal Care and Use Committee and were consistent with the guidelines of the International Association for the Study of Pain, the National Institutes of Health, and the American Physiological Society Guide for the Care and Use of Laboratory Animals.
R E S U L T S
In the electrophysiological experiments, recordings from 108 neurons located in the superficial dorsal horn and laminae I and II were made together. Of these neurons, 73% showed an increase of mEPSC frequency after capsaicin (0.1-0.2 M) and/or OLDA application, suggesting the presence of presynaptic TRPV1 receptors. The rest of the tested neurons (27%) did not respond to the TRPV1 agonists, suggesting an absence of TRPV1 receptors on their presynaptic contacts. The neurons with presynaptic TRPV1 receptors recorded at room temperature in slices from naïve control animals had basal control mEPSC frequencies 0.76 Ϯ 0.08 Hz (range from 0.08 to 2.37 Hz, n ϭ 53). The basal control mEPSC frequencies in neurons without presynaptic TRPV1 receptors were significantly higher (2.07 Ϯ 0.39 Hz; range from 0.65 to 7.55 Hz, n ϭ 23, P Ͻ 0.001).
mEPSC frequency of spinal cord DH neurons was increased by OLDA administration
Modulation of synaptic transmission at the first synapse in the nociceptive pathway was tested by application of three different concentrations of OLDA (0.1, 1, and 10 M, 3 min each, applied consecutively on each neuron) while recording mEPSCs from superficial DH neurons at room temperature (21-24°C). The increase in mEPSC frequency, expressed as a percentage of the control, after bath administration of 0.1 and 1 M OLDA was not statistically significant (102.1 Ϯ 3.1 and 130.2 Ϯ 2.9%, respectively; Fig. 1, A and B) . However, administration of 10 M OLDA increased the frequency of mEPSCs significantly to 202.2 Ϯ 23.4% (n ϭ 8, P Ͻ 0.001). Capsaicin, a potent TRPV1 agonist, known to increase mEPSC frequency in superficial DH neurons in a concentration-dependent manner via presynaptic TRPV1 receptors localized on primary afferents (Baccei et al. 2003; Yang et al. 1998) , was administered at the end of the experimental protocol to confirm input from central terminals of TRPV1-positive primary afferents. The mEPSC frequency was increased by capsaicin (0.1 M, 3 min) application in all of these DH neurons to 602.7 Ϯ 125.6% of the control. These results showed that a high concentration of the endogenous TRPV1 agonist OLDA (10 M) was needed to evoke a change in the mEPSC frequency in control slices.
Response to OLDA was blocked by TRPV1 antagonists
At room temperature, repeated application of OLDA (20 M, 3 min) with 10-min washout periods in between the applications led to a significant increase in the mEPSC frequency ( Fig. 2A) . Higher concentration of OLDA (20 M) was used in these experiment to ensure robust response of the neurons. The first and second responses to OLDA were similar compared with the original preapplication level (172.9 Ϯ 14.8 and 177.6 Ϯ 29.1%, respectively, n ϭ 6). During the 10-min washout period, the mEPSC frequency decreased close to the original control level (89.3 Ϯ 12.9%).
To test the specificity of TRPV1 receptor activation by OLDA administration, 10-min pretreatment with TRPV1 receptor antagonists SB366791 (10 M) or BCTC (10 M) followed by co-administration with OLDA (20 M, 3 min) was tested after the first control response. The first administration of OLDA without SB366791 (Fig. 2B ) elicited a significant increase in the mEPSC frequency (177.6 Ϯ 22.5%). During the following administration of SB366791, the mEPSC frequency did not return completely to the control level (120.3 Ϯ 11.4%), but this difference was not statistically significant from control. The second OLDA administration together with the TRPV1 antagonist did not change the mEPSC frequency (117.0 Ϯ 11.0%, n ϭ 6) from the preceding washout/antagonist period. There was no difference in the effect between the two TRPV1 antagonists. The first administration of OLDA without BCTC elicited an increase in the mEPSC frequency to 189.9 Ϯ 23.6% of the control. During the washout period, the mEPCS frequency decreased to 134.3 Ϯ 21.8% of the control. The second OLDA administration together with BCTC did not change the mEPSC frequency (130.3 Ϯ 20.1%, n ϭ 7, statistical significance between administrations of OLDA and OLDA ϩ BCTC was P Ͻ 0.05). These experiments confirmed that the changes in the mEPSC frequency after OLDA application were due to TRPV1 receptor activation.
Low concentration of OLDA increased the mEPSC frequency after PKC activation
Application of a high concentration of OLDA (10 M) was needed to increase the mEPSC frequency under control conditions. In another series of experiments, we tested our hypothesis that an ineffective low concentration of agonist OLDA (0.2 M) will elicit a response after activation of PKC, which has been shown to sensitize TRPV1 receptors because of phosphorylation ( tions of low concentration OLDA (4-min application, 10-min washout in between) did not evoke any response (Fig. 3A) under control conditions. Although the two consecutive applications of 0.2 M OLDA did not change the basal mEPSC frequency (93.3 Ϯ 7.1 and 98.4 Ϯ 6.0%, n ϭ 6), the following capsaicin application (0.1 M) evoked a robust increase in the mEPSC frequency to 1,430.6 Ϯ 490.5% (P Ͻ 0.001) from the control level.
In the first series of experiments, the effect of PMA application/PKC activation was tested at room temperature. Under this condition, the first low concentration OLDA (0.2 M, 4 min) application did not evoke any response, whereas that following PMA (1 M, 5 min) treatment increased the mEPSC frequency to 171.0 Ϯ 34.9% of the control (P Ͼ 0.05), and the second OLDA (0.2 M, 4 min) application that followed after the PMA washout period (10 min) elicited a robust increase of the mEPSC frequency to 246.1 Ϯ 40.6% of the control value (P Ͻ 0.001, n ϭ 7, data not shown). Capsaicin (0.1 M) applied at the end of the experiment increased the mEPSC frequency even further to 1,845.2 Ϯ 516.5%. To determine possible influences of the bath temperature on the responses, the same experimental protocol was used at defined temperatures of 24 and 34°C (Fig. 3B) . The mEPSC frequency expressed as percentage of the spontaneous activity before any treatment was changed during the consecutive administration of the drugs OLDA, PMA, and OLDA to 100.1 Ϯ 7.6, 142.5 Ϯ 18.4, and 264.1 Ϯ 45.1% (n ϭ 10) at 24°C (Fig. 3, B and C) and to 108.9 Ϯ 7.6, 156.6 Ϯ 38.6, and 272.8 Ϯ 60.9% (n ϭ 10) at 34°C (Fig. 3, B and D) . At both temperatures tested, the first OLDA administration did not change the basal mEPSC frequency, whereas the second OLDA treatment after PMA application increased significantly the mEPSC frequency to a similar extent. The mEPSC amplitude did not change significantly during the consecutive administration of the drugs. The values were 27.33 Ϯ 1.80 (CTRL), 27.01 Ϯ 2.56 (OLDA), 25.88 Ϯ 2.62 (PMA), and 24.62 Ϯ 2.45 pA (OLDA) at room temperature.
The increase in bath temperature from 24 to 34°C had a significant impact on the frequency and amplitude of the mEPSCs on its own (Fig. 4, A and B) . The mEPSC frequency and mean amplitude increased significantly at 34°C under different experimental conditions (CTRL, OLDA, PMA, OLDA) compared with the frequency and amplitude values at 24°C as 100%. The relative increase in frequency and amplitude of mEPSCs caused by a rise in bath temperature to 34°C was similar under both control and experimental conditions.
Low concentration of OLDA increased the mEPSC frequency after BK administration
To study the possibility that the sensitization of TRPV1 receptors induced by BK will lead to their activation by a low concentration of OLDA (0.2 M), bradykinin pretreatment was used instead of phorbol ester. The first OLDA application (4 min) did not change the mEPSC frequency (103.4 Ϯ 6.4% of the control). The BK (10 M, 3 min) application induced a robust increase of mEPSC frequency (195.0 Ϯ 27.4%) that diminished to a level close to control values (118.9 Ϯ 13.5%) after ϳ10 min of the washout period (Fig. 5A) . The following OLDA application evoked a strong rise in mEPSC frequency (177.5 Ϯ 23.4%) that was not present during the first application. Both mEPSC frequency increases were significantly different from the control situation (n ϭ 9, P Յ 0.001).
The BK application also induced an increase in the mEPSC amplitude, as is evident from the rightward shift in the cumulative frequency amplitude histogram of one neuron (Fig. 5B) . Of the nine neurons tested, five showed an mEPSC amplitude increase (mean 136 Ϯ 7.6%, P Ͻ 0.05) after bath administration of BK. There was no significant change of the mEPSC amplitude under the rest of the experimental conditions. FIG. 2. Repeated administration of OLDA elicited an increase in mEPSC frequency that was prevented by a transient receptor potential vanilloid (TRPV1) antagonist. A: 1st and 2nd OLDA (20 M) administration elicited the same increase in mEPSC frequency under control conditions (n ϭ 6, **P Ͻ 0.01). B: increase in the mEPSC frequency was prevented by TRPV1 antagonist SB366791 (10 M) pretreatment (n ϭ 6, **P Ͻ 0.01).
During peripheral inflammation, a low concentration of OLDA evoked an increase of mEPSC frequency in spinal cord DH neurons
Subcutaneous injection of mixture of carrageenan and kaolin was used to induce peripheral inflammation. Low concentration OLDA (0.2 M, 4 min) solution was tested on lumbar spinal cord slices 24 h after the injection at defined temperature conditions (24 or 34°C). The frequency of mEPSCs remained unchanged from the spontaneous activity when OLDA was applied in the control animals: 100.1 Ϯ 7.6 (n ϭ 10, 24°C) and 108.9 Ϯ 7.6% (n ϭ 10, 34°C), when 100% was defined as the control frequency at the given bath temperature. However, the same concentration of OLDA evoked a significant increase of mEPSC frequency to 155.6 Ϯ 5.4 (P Ͻ 0.001, n ϭ 10, 24°C) and 157.3 Ϯ 10.4% (P Ͻ 0.001, n ϭ 10, 34°C) in spinal cord slices from inflamed animals. This increase in mEPSC frequency was significant compared with the responses in control animals (Fig. 6, A and B) . The extent of increase of the mEPSC frequency evoked by OLDA administration in slices from animals with peripheral inflammation was similar at both temperatures tested.
The absolute frequencies of mEPSCs recorded in the beginning of each experiment in the slices from animals with peripheral inflammation were significantly higher compared with the controls (Fig. 7A) . This was true both at 24°C (control: 0.45 Ϯ 0.13 Hz, n ϭ 10; inflamed: 1.25 Ϯ 0.30 Hz, n ϭ 10) and at 34°C (control: 2.32 Ϯ 0.61 Hz, n ϭ 10; inflamed: 5.10 Ϯ 0.91 Hz, n ϭ 10). The mEPSC frequency recorded in the slices from the inflamed animals was higher to a similar extent at both temperatures when expressed in percent of the relevant values from the control animals (278.8 Ϯ 62.0% at 24°C and 220.0 Ϯ 37.1% at 34°C).
There was not a significant difference in the mEPSCs amplitudes between the control and experimental groups at either temperature (Fig. 7B) . Mean amplitudes of the mEPSCs in controls and in slices from animals with inflammation were 27.33 Ϯ 1.80 (n ϭ 10) and 24.36 Ϯ 2.33 pA (n ϭ 10) at 24°C and 39.29 Ϯ 2.38 (n ϭ 10) and 32.78 Ϯ 2.63 pA (n ϭ 10) at 34°C, respectively.
The bath temperature rise from 24 to 34°C induced a significant increase of the mEPSCs frequency and amplitude to 518.8 Ϯ 128.5 and 143.8 Ϯ 8.3% in slices from control animals and to 409.4 Ϯ 69.0 and 134.6 Ϯ 10.2% in the slices from animals with peripheral inflammation, respectively.
Intrathecal application of OLDA induced thermal hyperlagesia
In behavioral experiments, the effect of intrathecal application of OLDA on PWLs to thermal stimuli was tested. Intrathecal application of 100 M OLDA and vehicle application did not have any effect on PWL. PWL before 100 M OLDA application was 19.5 Ϯ 0.3 s and did not change 1, 2, or 4 h after application (19.5 Ϯ 0.1, 19.6 Ϯ 0.1, and 19.9 Ϯ 0.1 s, respectively, n ϭ 4). Intrathecal injection of 500 M OLDA induced a decrease of the PWL from the control (18.9 Ϯ 0.4 s, n ϭ 4) at 1 h after the application (17.3 Ϯ 0.2 s, P Ͻ 0.01), with a maximum at 2 h (15.3 Ϯ FIG. 3 . A low concentration solution of OLDA (0.2 M) was ineffective under normal conditions but increased the mEPSC frequency after protein kinase C (PKC) activation. A: 1st and 2nd administration of a low concentration of OLDA (0.2 M) did not evoke any significant change in mEPSC frequency at room temperatures ranging between 23 and 25°C (n ϭ 6, SE). B: low concentration OLDA increased the mEPSC frequency after PMA administration at defined temperatures of 24 and 34°C. The effect of OLDA was less than the effect of subsequent capsaicin administration. C and D: low concentration of OLDA administered after PMA increased the mEPSC frequency significantly at temperatures of 24 and 34°C (n ϭ 10, ***P Ͻ 0.001, SE). 0.2 s, P Ͻ 0.001) and slow return to the control level at 4 (17.2 Ϯ 0.2 s, P Ͻ 0.01) and 24 h (17.9 Ϯ 0.4 s, P Ͼ 0.05). These data suggested presence of thermal hyperalgesia following intrathecal OLDA application.
D I S C U S S I O N
TRPV1 receptors are part of the TRP family of channels and have been shown to play an important role in a number of pathological pain states, thus representing an important target for pain therapy (Levine and Alessandri-Haber 2007) . In our experiments, we concentrated on TRPV1 receptors present at the central branches of DRG neurons projecting to the spinal cord that have a modulatory role in nociceptive transmission. To activate TRPV1 receptors, we used OLDA, a putative endogenous TRPV1 agonist that was shown to be present in the brain (Chu et al. 2003) . Our behavioral tests showed that intrathecal injection of OLDA leads to thermal hyperlagesia, presumably because of activation of presynaptic TRPV1 receptors in the spinal cord. This is in agreement with previous findings of peripheral thermal hyperalgesia after OLDA intraplantar injection (Chu et al. 2003) .
In our experiments, a relatively high concentration of OLDA (10 M) was needed to evoke a significant increase in mEPSC frequency recorded from superficial dorsal horn neurons. However, only a much lower concentration of OLDA (0.2 M) was sufficient to evoke an increase in mEPSC frequency after PKC activation by phorbol esters, BK application, or when recordings were made in slices isolated from animals with experimentally induced peripheral inflammation. These results showed that TRPV1 receptors present at the presynaptic endings of primary afferents in the spinal cord can be activated by much lower concentrations of endogenous agonists under pathological conditions when they become phosphorylated and thus have a much more potent modulatory effect on nociceptive transmission. FIG. 4. The effect of bath temperature increase from 24 to 34°C on mEPSC frequency and amplitude during consecutive application of control solution, OLDA (0.2 M), phorbol 12-myristate 13-acetate (PMA; 1 M), and OLDA (0.2 M). The temperature increase to 34°C elicited a significant change in both mEPSC frequency (A, n ϭ 9, **P Ͻ 0.01) and amplitude (B, n ϭ 9, ***P Ͻ 0.001, SE) under all experimental conditions when the values at 24°C were taken as 100%. elicited an acute increase of mEPSC frequency after the washout effect diminished almost to control level. A 2nd administration of OLDA again increased the mEPSC frequency (n ϭ 9, ***P Ͻ 0.001, †P ϭ 0.001, SE). B and C: acute administration of BK increased the amplitude of mEPSCs. Cumulative distribution plot of mEPSCs amplitudes in 1 neuron (P Ͻ 0.001, B) and normalized means (n ϭ 5, *P Ͻ 0.05, SE, C).
Effect and specificity of spinal TRPV1 receptor activation by OLDA
In the described experiments, the presynaptic TRPV1 receptors activation was evaluated as a change in mEPSC frequency in dorsal horn neurons. It was shown previously that glutamatergic transmission may be enhanced by activation of these receptors by capsaicin (Baccei et al. 2003; Nakatsuka et al. 2002; Sikand and Premkumar 2007; Ueda et al. 1993; Yang et al. 1998) . Although capsaicin is a well-established powerful exogenous TRPV1 agonist, we used OLDA, an endogenous TRPV1 agonist, that was shown to be only a weak agonist on cannabinoid CB1 receptors (Chu et al. 2003; Szolcsanyi et al. 2004) , to explore the possibility of spinal cord TRPV1 receptors activation in vivo. In our experiments, 10 M OLDA concentration was needed to evoke a significant change in mEPSC frequency. This corresponds well with the EC 50 of 1.8 M found for rat TRPV1 receptor activation by OLDA in cell culture (Szolcsanyi et al. 2004 ) and an EC 50 of 34.5 M for thermal hyperalgesia after subcutaneous OLDA injection in the rat paw (Chu et al. 2003) when different experimental conditions are considered. However, the potency of OLDA to activate human TRPV1 receptors was shown to be significantly higher, with an EC 50 of only 36 nM (Chu et al. 2003) .
The specificity of the TRPV1 receptor activation by OLDA in our experiments was confirmed by blocking the responses with two TRPV1 antagonists: SB366791 and BCTC. BCTC was shown to also inhibit transient receptor potential melastatin 8 (TRPM8) receptors (Weil et al. 2005 ). However, in our preparation, the effect of BCTC application was identical to the selective TRPV1 antagonist SB366791. It is most likely that, in vivo, other potential endogenous TRPV1 receptor agonists could also activate these presynaptic TRPV1 receptors, especially under pathological conditions, when the TRPV1 sensitivity is increased. One of the potential candidates could be anandamide, which was shown previously to activate spinal cord and medullary TRPV1 receptors in a higher concentration, whereas a lower concentration had an antinociceptive effect caused by cannabinoid receptor activation (Horvath et al. 2008; Jennings et al. 2003; Tognetto et al. 2001) . Cooperation between the cannabinoid (CB1) and TRPV1 receptors could play an important role in the modulation of nociceptive transmission at the spinal cord level, especially as most of the putative endogenous agonists may activate both types of receptors. Although the activation of TRPV1 receptors is excitatory, the activation of CB1 receptors was shown to induce presynaptic inhibition of postsynaptic excitatory currents at the spinal cord level (Morisset and Urban 2001) .
Effect of phorbol ester and BK application
Phorbol esters are potent activators of PKC, and their application at the spinal cord level has numerous modulatory effects, including sensitization of spinothalamic tract neurons (Palecek et al. 1994) , an increase of mEPSC frequency in spinal cord slices (Hori et al. 1996) , and mechanical allodynia, thermal hyperalgesia, and enhanced release of excitatory amino acids (Palecek et al. 1999) . PKC-independent enhancement of glutamatergic synaptic transmission was also observed (Sikand and Premkumar 2007) ; this could be caused by direct FIG. 6. During peripheral inflammation, a low concentration of OLDA (0.2 M) increased the mEPSC frequency at both temperatures: 24 and 34°C. There was no change in control animals. A: recording from control and experimental groups of animals at 24°C. B: normalized means: control animals at both temperatures (n ϭ 10, SE) and experimental animals at both temperatures (n ϭ 10, SE, ***P Ͻ 0.001).
FIG. 7. Peripheral inflammation increased basal mEPSC frequency in DH neurons without change in amplitude. A: increase of mEPSC frequency induced by peripheral inflammation at 24 and 34°C (n ϭ 10 in control and experimental groups of animals, SE, *P Ͻ 0.05). B: peripheral inflammation did not evoke a change of mEPSC amplitude (n ϭ 10 in control and experimental groups of animals, SE). action on presynaptic proteins (Lou et al. 2005; Rhee et al. 2002 ). An increased concentration of the TRPV1 agonist anandamide observed in DRG neurons after phorbol ester application may also have an amplification effect (Vellani et al. 2008) . In embryonic rat DRG-DH neuronal cocultures, phorbol esters induced sensitization of presynaptic TRPV1 receptors in a PKC-dependent manner, so that they were partially activated by body temperature at 37°C (Sikand and Premkumar 2007) . This is in good agreement with previous findings that phorbol esters potentiate TRPV1 receptor-mediated responses in cultured cells (Premkumar and Ahern 2000; Vellani et al. 2001 ). In our experiments, phorbol ester application induced a transient increase in mEPSC frequency that diminished before the second application of low concentration OLDA, which evoked a robust increase in mEPSC frequency. This suggests that the dose-response relation of TRPV1 receptor activation by OLDA was shifted leftward, similar to capsaicin-evoked currents in DRG cultured neurons after phorbol ester application (Vellani et al. 2001) .
Phorbol esters are very potent but unphysiological activators of PKC (Castagna et al. 1982) . To approach the in vivo conditions, we used the inflammatory mediator BK, which is known to sensitize TRPV1 receptors (Premkumar and Ahern 2000) and was shown to be increased significantly in the spinal cord after intraplantar capsaicin injection (Wang et al. 2005) . The BK application induced a strong increase in mEPSC frequency and amplitude in our experiments. This finding correlates well with the recent demonstration that BK acts via BK 2 receptors presynaptically to increase glutamate release and postsynaptically to increase the sensitivity of glutamate ionotropic receptors in spinal cord superficial DH synapses (Wang et al. 2005) . In cultured neurons, BK also enhanced mEPSC frequency and responses to capsaicin application in a PKC-dependent manner (Sikand and Premkumar 2007) . In vivo BK-induced thermal hyperalgesia after intraplantar application was shown to be dependent on the TRPV1 receptors, because it was abolished in TRPV1 knockout mice (Chuang et al. 2001) . After BK pretreatment, a low concentration of OLDA increased mEPSC frequency in DH neurons because of activation of presynaptic TRPV1 receptors. Based on the published evidence, it seems plausible to suggest that sensitization of TRPV1 receptors by BK included activation of different signaling pathways, such as PKC (Cesare et al. 1999; Sikand and Premkumar 2007; Sugiura et al. 2002) , phospholipase C, inositol triphosphate and diacylglycerol (Burgess et al. 1989; Ferreira et al. 2004) , phospholipase A 2 , and generation of 12-lipoxygenase metabolites (Hwang et al. 2000; Shin et al. 2002) or cyclooxygenase activation (Tang et al. 2004 ). In our experiments, sensitization of spinal TRPV1 receptors either by phorbol ester or BK enhanced sensitivity to low concentrations of endogenous agonist. This suggests that, under in vivo conditions, similar TRPV1 receptor sensitization may occur because of PKC/PKA activation by various other neuroinflammatory molecules and lead to modulation of synaptic activity in the TRPV1-expressing pain pathway.
Effect of bath temperature
The experiments in this study were generally performed under controlled "room" temperature (24°C), but in some cases, the temperature was raised to 34°C, closer to normal body temperature. At 37°C (not reported), it was very difficult to keep good recording parameters throughout the extended duration of the experiment. The rise of the bath temperature from 24 to 34°C resulted in a very dramatic increase of both mEPSCs frequency and amplitude, most likely reflecting changes at both presynaptic and postsynaptic sites. The magnitude of the increase was very similar under control and different experimental conditions, suggesting involvement of TRPV1 unrelated mechanisms such as an increase of neurotransmitter release caused by changes in the kinetics of synaptic vesicle exocytosis and endocytosis (Yang et al. 2005 ); a decreased energy requirement for Ca 2ϩ -independent fusion of the synaptic vesicles; an increase in the refilling rate of the readily releasable pool (RRP) of synaptic vesicles ; and acceleration of AMPA receptor reaction kinetics leading to increased activation of higher-conducting open states of AMPA channels (Postlethwaite et al. 2007) .
It is well established that the threshold temperature for TRPV1 receptor activation is significantly lowered following phosphorylation of the receptor. Under control conditions, the TRPV1 receptor expressed in HEK cell cultures is activated at ϳ42°C, whereas after bradykinin or phorbol ester application, the channels open at ϳ32°C (Sugiura et al. 2002) . Activation of presynaptic TRPV1 receptors at 37°C after PKC activation was shown in embryonic DRG-DH cocultures (Sikand and Premkumar 2007) . In our experiments, the increase in mEPSC frequency after phorbol ester and with a second OLDA application was similar at both 24 and 34°C, suggesting that there was not a significant activation of TRPV1 receptors induced by the 34°C bath temperature. It is most likely that the 34°C temperature of the bath was below the TRPV1 receptors activation threshold, even after the PKC activation. However, functional differences of the TRPV1 receptors and the presynaptic ending apparatus between the different experimental models used (cell cultures, spinal cord slices) are also plausible.
Role of spinal TRPV1 receptors after peripheral inflammation
The importance of spinal TRPV1 receptors for pain modulation is recently gaining more attention and experimental evidence (Spicarova and Palecek 2008) . After peripheral inflammation, up-regulation of TRPV1 receptors (Luo et al. 2004 ) and TRPV1 mRNA in the spinal cord DH (Tohda et al. 2001 ) was shown, and intrathecally applied TRPV1 receptor antagonist was shown to block thermal hyperalgesia (Cui et al. 2006; Luo et al. 2008) . Responses of spinal cord wide dynamic range neurons to light mechanical stimulation were attenuated by TRPV1 antagonist after peripheral inflammation (McGaraughty et al. 2008) . Bath application of a TRPV1 antagonist in the spinal cord slice preparation from inflamed animals inhibited glutamatergic transmission through a presynaptic mechanism (Lappin et al. 2006 ).
Our results gave clear evidence that spinal cord presynaptic endings were more sensitive to endogenous agonists after peripheral inflammation, presumably because of an increased level of proinflammatory mediators, such as BK, and subsequent TRPV1 receptor phosphorylation and/or up-regulation. Sensitization of spinal cord TRPV1 receptors during pathological conditions seem to be a significant mechanism involved in
